经验

Fangdd $78 Million – IPO

November 6, 2019

Cooley advised Fangdd on its $78 million initial public offering of 6,000,000 American depositary shares, each representing 25 class A ordinary shares. The underwriters have a 30-day option to purchase up to 900,000 additional shares. The transaction represents Cooley’s first completed IPO out of its newly launched Hong Kong office. Partner Will Cai led the Cooley team advising Fangdd. Founded in 2011 by former real estate agents Yi Duan and Xi Zeng, Fangdd now trades its securities on the Nasdaq Global Select Market under the symbol “DUO.”

Read more

Related contacts

蔡华
合伙人, 香港
袁晓通
资深顾问律师, 北京
张捷
顾问, 香港
Aaron Pomeroy
Partner, 科罗拉多
Patrick Sharma
Associate, 洛杉矶
Francis Wheeler
Senior Counsel, 科罗拉多
Charlie Kim
Partner, 圣地亚哥
Darren DeStefano
Partner, 雷斯顿
余仙
香港办事处主管合伙人, 香港
刘颖
律师, 香港

Related Practices & Industries

Legend Biotech - $487 Million IPO

June 9, 2020

Cooley advised Legend Biotech on its $487.3 million initial public offering of 21,188,750 American Depository Shares (ADSs). Legend Biotech, whose securities now trade on the Nasdaq Global Select Market under the symbol “LEGN”, is global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Partners Div Gupta, Rob Phillips, Will Cai, Michael Yu and Rich Segal led the Cooley team.

Related contacts

Div Gupta
Partner, 纽约
蔡华
合伙人, 香港
余仙
香港办事处主管合伙人, 香港
Richard Segal
Partner, 纽约
Mark Ballantyne
Partner, 雷斯顿
Denny Won
Partner, 旧金山
Jayne M. Munger
Associate, 纽约
刘颖
律师, 香港
Lila Hope
Partner, 帕罗奥图

Related Practices & Industries

Keymed Biosciences – HK$3.1 Billion IPO

July 8, 2021

Cooley advised biotechnology company Keymed Biosciences on its HK$3.1 billion (US$400 million) initial public offering on the Hong Kong Stock Exchange. Partners Yiming Liu, Michael Yu and Will Cai led the Cooley team advising Keymed Biosciences on its public debut, which also included Yiying Wang, Xiaoyu Xu, Kaiting Yang, Henry Wang, Bridget Wang and Iris Yang.

Read more

Related contacts

刘毅铭
上海办事处主管合伙人, 上海
余仙
香港办事处主管合伙人, 香港
蔡华
合伙人, 香港
王一盈
顾问律师, 上海
杨凯婷
顾问律师, 香港
Calvin Lee
Associate, 纽约

Related Practices & Industries

Smart Share Global – $150 Million IPO

March 31, 2021

Cooley advised the underwriters on Smart Share Global’s $150 million initial public offering of 17,650,000 American Depositary Shares. Goldman Sachs, Citigroup Global Markets  and China Renaissance Securities (Hong Kong) Limited acted as joint bookrunners and for the offering. Smart Share Global, whose securities now trade on the Nasdaq Global Select Market under the symbol EM, is a consumer tech company providing mobile device charging service. Partners Will Cai, Michael Yu and David Peinsipp led the Cooley team.

Related contacts

蔡华
合伙人, 香港
余仙
香港办事处主管合伙人, 香港
David Peinsipp
Partner, 旧金山
李正洋
国际法律项目经理, 香港
张捷
顾问, 香港

Related Practices & Industries

Asymchem Laboratories – HK$7.15 Billion IPO

December 15, 2021

Cooley advised Asymchem Laboratories, a contract development manufacturing organization (CDMO) serving the global pharmaceutical industry, on its HK$7.15 billion (US$916 million) initial public offering – marking the largest healthcare IPO in Hong Kong this year – of 18,415,400 H shares, which now trade on the Hong Kong Stock Exchange. Partners Yiming Liu and Michael Yu led the Cooley team advising Asymchem.

Read more

Related contacts

刘毅铭
上海办事处主管合伙人, 上海
余仙
香港办事处主管合伙人, 香港
王一盈
顾问律师, 上海
杨凯婷
顾问律师, 香港
武梦超
律师, 北京
Cindy Pan
International Legal Project Manager, 香港
Rick Jantz
Associate, 洛杉矶
Francis Wheeler
Senior Counsel, 科罗拉多

Related Practices & Industries

查看全部

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.